Added to YB: 2024-08-15
Pitch date: 2024-06-30
BIO [bullish]
Bio-Rad Laboratories, Inc.
+12.51%
current return
Author Info
No bio for this author
Company Info
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
Market Cap
$8.5B
Pitch Price
$273.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
17.39
P/E
-12.75
EV/Sales
3.30
Sector
Life Sciences Tools and Services
Category
turnaround
Longleaf Partners Global Fund Commentary Portfolio Holding: Bio-Rad Laboratories, Inc.
BIO: Life sciences co. underperforming due to delayed growth. Strong balance sheet, opportunistic share repurchases. Margins below peers suggest improvement potential. Undervalued Sartorius stake. Anticipate return to solid growth sooner than market expects. Peers priced for growth despite tough industry environment. No new competitive threats since investment.
Read full article (1 min)